Cergentis is sponsoring the 6th Cell Culture & Bioprocessing Congress in London between November 6-7.

Our Sales Manager will present the TLA technology and its applications in the complete genetic characterisation of transgenic (CHO) cell lines.

The presentation is scheduled for Day 1, between 14.50 and 15.20 in Conference room 1.

During the presentation, the following will be discussed: 

• Introduction of the TLA technology for targeted complete Next Generation Sequencing
• TLA and its applications in the complete sequencing of transgenes, integration sites and gene editing events
• TLA and the quality control and selection of cell-lines and the assessment of their genetic stability and clonality

If you are also attending, we look forward to seeing you there.

More information

For more information about our TLA-based transgene sequencing service, click here.